Founded in early 2005, StratiCELL is a leading company assisting the cosmetic, pharmaceutical and chemical industries to the safety and efficacy evaluation of their actives and products by means of in vitro models and methods in a GLP-compliant environment.

StratiCELL is a skin model manufacturer and a project-driven services provider for in vitro testing, with a particular emphasis on testing of skin care actives and products

Previous News

About our previous news.  

 

Since 2006 StratiCELL is approved the French Minister of Research

French companies are granted for tax deduction (Crédit Impôt Recherche)


StratiCELL enters a gentlemen's agreement with SkinEthic,

... which consists in the use of validated EPISKIN TM tissues for skin toxicity testing services at StratiCELL.


StratiCELL is nominated for "Le Grand Prix Wallon de l'Entrepreneuriat - Innovation ".


StratiCELL is participating in 5 European Research Projects

  • MarkAge (FP7) (HEALTH-2007-2.2.2-3, European Study to Establish Biomarkers of Ageing): In the Integrated Project MARK-AGE a comprehensive and coherent Europe-wide population study will be conducted, aiming at the identification of powerful biomarkers of human ageing.
  • Skintreat
    SkinTreat main objective is to realize the promise of customized remedy in the context of managing skin syndromes. The consortium intends to develop and validate nano-chemical and bio- technologies to achieve an accurate match between drugs, drug delivery vehicles, skin diseases and sub pathogenic skin conditions per individual. The project will lead to a new generation of pharmaceutical products, as well as consumer personalized service, which tailor a remedy per customer's needs.The development of personalized skin therapy protocols will involve non invasive methods as well as minimal invasive skin sampling, thus achieving an accurate diagnostics of skin condition, an extensive analysis of biological markers and the establishment of biological profiles corresponding to skin diseases and skin sub pathologic conditions. A bio-informatics data mining algorithm will be developed, together with multifunctional biomarker analysis software and a computerized decision support system, to enable a refined personalized diagnosis then to propose a personalized prescription. SKINTREAT concept will be evaluated by a pilot study.
  • Linkage
    LINK-AGE is a Coordination Action within the 6th Framework Programme of the European Commission that aims at significantly extending existing European research in biogerontology. Such research is still fragmented, limiting the ability to progress in an area of great economic and social importance for the future of Europe. Coordination and Consolidation of European research in this field will represent a step forward to the formation of a European College of Biogerontology.
    LINK-AGE will support a closely coordinated programme of topic working groups, workshops and conferences, summer schools, and dissemination activities. Through its spreading activities, LINK-AGE will develop effective links with the wider public and industry, in order that translation into benefit of emerging knowledge of the underpinning science of healthy ageing can be exploited as rapidly as possible.
    The LINK-AGE Coordination Action includes 14 full members from 10 European countries (including one SME from Belgium) and is coordinated by the Facultés Universitaires Notre-Dame de la Paix de Namur in Belgium. Several other laboratories participate to some of the LINK-AGE actions as associates members.
  • WhyWeAge - A road map for European research on molecular aspects of healthy ageing
  • Matiss

 

Old News

  • May 2007 - StratiCELL is laureate of 2007 Alfers Price (for innovative company of the Province of Namur)
    StratiCELL is approved by the French Minister of Research, allowing French companies to have tax deduction
    Crédit Impôt Recherche
  • February 2007 - StratiCELL relocates its site of production and operational activities to CREALYS scientific park: Gembloux, Les Isnes, close to Namur.
  • November 2006 -StratiCELL became a full member of the European Partnership for Alternative Approach ( EPAA ), and actively participated to the conference "Europe goes alternative" (Brussels, December 18, 2006)

Past Events

  • Skin Ageing World Congress, Malta
  • EuroBIO, Lille.
  • 39th Annual ESDR meeting, 9 - 12 September 09, Budapest - Hungary
  • 7th WC conference on Alternative and Animal Use in the Life Sciences, 30 August to 3 September, Rome.
  • Forinvitox Forum - 12 to 14 May, Stockholm.
  • In Cosmetics - 21-23 April, Munich
  • Skin and Formulation - 9-10 March, Versailles
  • Cosmetagora - 12-13 January 2009, Paris Boulogne
  • La peau et son vieillissement - données récentes 2-3 December 2008, Paris
  • IFCC 6-9 October 2008, Barcelona, Spain
  • ESTIV 25-28 September 2008, Stockholm.
  • 15th Congress on Alternatives to Animal Testing & MEGAT 19-21 September 2008, Linz, Austria
  • HBA, New York City, on 9, 10,and 11 September 2008
  • FCE Cosmetique 27-29 May 2008, Sao Paulo, Brazil
  • In-cosmetics 15-17 April 2008, Amsterdam, The Netherlands
  • Accelerating the Future 2008, March 2008, New York City, US
  • Eurobio 2007, October 2007, Lille, France
  • Linkage Summer School, 18-22 September 2007 in 'Les Diablerets', Switzerland.
  • In-Cosmetics, April 2007, Paris, France
  • Bioeurope, March 2007, Milan, Italy
  • EPAA, "Europe goes alternative" (December 18, 2006, Brussels, Belgium)( EPAA )
  • Bio-Europe, November.6-8, Düsseldorf, Germany
  • Econag, November 2006, Innsbruck, Austria
  • Eurobio 2006, Oct 25-27 2006 , Paris, France
  • 2nd Symposium on Skin and Formulation, Octobre 9-10 2006, Versailles, Paris, France
  • INVITOX, Oct.2-5 2006, Ostend, Belgium
  • In-Cosmetics, April 2006, Barcelona, Spain